Clinical Trial Update: Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer

View source ↗

Summary

A completed clinical trial update examining how body mass index and lipid metabolism may influence outcomes of anti-PD-1 immunotherapy in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anti-PD-1 immunotherapy

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colo-rectal Cancer | Status: COMPLETED